Instil Bio Inc. (TIL)

Instil Bio Inc. (TIL) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $41.6M; returns 1 day +2.5%, 1 week -1.2%, 1 year -69.3%.

Instil Bio, Inc. (TIL) is a clinical-stage biopharmaceutical company focused on developing a portfolio of innovative therapies, particularly cell therapies for solid tumors. Their strategy involves sourcing, acquiring, and advancing drug candidates that address areas of high unmet medical need. Instil Bio's subsidiary, Axion Bio, Inc., has been involved in licensing bispecific antibody programs.

Groups TIL belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Clinical Stage
• Healthcare
• Life Sciences
• Oncology
• Cancer Therapeutics
• Unmet Medical Needs

TIL financial model: income statement, cash flow and balance sheet